|
|
ECONOMIC ANALYSIS
Questions d'économie de la santé (Issues in Health Economics)

Has the Introduction of Mandatory Deductibles Modified Patients’ Prescription Drug Purchasing Behaviour? 
Kambia-Chopin B., Perronnin M.
Issues in Health Economics (Questions d'économie de la santé) n° 158. 2010/10

Cost-of-Illness Studies: a Five-Country Methodological Comparison - Australia, Canada, France, Germany and the Netherlands.
Heijink R.(RIVM), Renaud T. (Irdes), 2009/06.
Questions d'économie de la santé n° 143

GPs teamed up with nurses: a skill mix experiment improves management ot type 2 diabetes patients
Bourgueil Y., Le Fur P., Mousquès J., Yilmaz E. 2008/11
Questions d'économie de la santé n° 136

Delisting of mucolytics and expectorants: what is the impact on general practitioners’ prescribing?
Devaux M., Grandfils N., Sermet C., 2007/12
Questions d'économie de la santé n° 128

Helping the poor to acquire a complementary health insurance: an initial appraisal of the ACS system
Franc C., Perronnin M., 2007/04
Questions d'économie de la santé n° 121

Hospital at home, an economical alternative for rehabilitative care.
Afrite A., Com-Ruelle L., Or Z., Renaud T., 2007/02
Questions d'économie de la santé n° 119

Expenditure on prevention and care by disease in France
Fénina A., Geffroy Y., Minc C., Renaud T., Sarlon E, Sermet C., 2009/07
Questions d'économie de la santé n° 111
Working papers

Out-of-Pocket Maximum Rules under a Compulsory Health Care Insurance Scheme:
A Choice between Equality and Equity 
Debrand T. (Irdes), Sorasith C. (Irdes)
Working paper n° 34. 2010/11
Abstract
Published in...

Are Health Problems Systemic? Politics of Access and Choice under Beveridge and Bismarck Systems. 
Or Z. (Irdes), Cases C. (Irdes), Lisac M. (Bertelsmann Stiftung), Vrangbæk K. (University of Copenhagen), Winblad U. (Uppsala University), Bevan G. (London School of Economics).
Working paper n° 27. 2009/09
Abstract

One price for all? Sources of cost variations between public and private hospitals.
Or Z., Renaud T., Com-Ruelle L.
Working paper n° 25. 2009/05
Abstract
Document only in French 

Income and the Demand for Complementary Health Insurance in France. 
Grignon M. (McMaster University; Associate researcher, Irdes) Kambia-Chopin B. (Irdes).
Working paper n° 24, 2009/04
Abstract

The preferred doctor scheme: A political reading of a French experiment of Gate-keeping. 
Naïditch M. (Denis Diderot University, Irdes), Dourgnon P. (Irdes)
Working paper n° 22, 2009/03
Abstract

Dynamic Estimation of Health Expenditure: A new approach for simulating individual expenditure. 
Albouy V. (Insee), Davezies L. (Insee), Debrand T. (Irdes)
Working paper n° 20, 2009/01
Abstract

Comparability of Health Care - Responsiveness in Europe - Using anchoring vignettes from SHARE. 
Sirven N. (Irdes), Santos-Eggimann B. (IUMSP), Spagnoli J. (IUMSP).
Working paper n° 15, 2008/09
Abstract

Sickness and injury leave in France : moral hazard or strain? 
Grignon M. (McMaster University), Renaud T. (Irdes).
Working paper n° 4, 2007/02
Abstract
Reports
1733
Team work experimentation involving general practitioners and nurses in the management of patients with type 2 diabetes. Economic evaluation of the French experiment ASALEE. Bourgueil Y., Le Fur P., Mousquès J., Yilmaz E., Irdes report, 2008/12.
English abstract
1689
At home or at hospital? A comparative cost analysis of rehabilitative care. Afrite A., Com-Ruelle L., Or Z., Renaud T., Irdes report, 2008/06.
English abstract
1651
The cost of colon cancer in Île-de-France Geographical, clinical and therapeutic considerations.
Com-Ruelle L., Lucas-Gabrielli V., Renaud T., Irdes report, 2006/11.
English abstract
1484
Assessment of the cost of home hospitalisation in 1999-2000.
Aligon A., Com-Ruelle L., Renaud T., Lebrun E. Irdes report, 2003/06.
English abstract
1480
Health care expenditure by pathology: a prototype based on 1998.
Paris V., Renaud T., Sermet C., Irdes report, 2003/05.
English abstract
Publications by Irdes researchers in other venues
1841
Comparability of Health Care Responsiveness in Europe.
Sirven N., Santos-Eggimann B., Spagnoli J., Social Indicators Research, vol 105, n° 2, 2012, 255-271.
On Springerlink site 
1819*
Building bridges between health economics research and public policy evaluation, 2010 IRDES Workshop on Applied Health Economics and Policy Evaluation.
Debrand T., Dourgnon P. Expert Review of Pharmacoeconomics & Outcomes Research, vol 10, n° 6, 2010/12, 637-640.
Sur le site Expert reviews 
1818*
Policies to enhance prescribing efficiency in Europe: findings and future implications.
Godman B., Shrank W., Andersen M., Berg C., Bishop I., Burkhardt T., Garuoliene K., Herholz H., Joppi R., Kalaba M., Laius O., Lonsdale J., Malmström R.E., Martikainen J.E., Samaluk V., Sermet C., Schwabe U., Teixeira I., Tilson L., Tulunay F.C., Vlahovic-Palcevski V., Wendykowska K., Wettermark B., Zara C., Gustafsson L.L., Frontiers in pharmacology, vol 1, article 141, 2011/01, 1-16.
Sur le site Frontiers 
1815*
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization : changes seen and global implications.
Godman B., Shrank W., Andersen M., Berg C., Bishop I., Burkhardt T., Garuoliene K., Herholz H., Joppi R., Kalaba M., Laius O., McGinn D., Samaluk V., Sermet C., Schwabe U., Teixeira I., Tilson L., Tulunay F.C., Vlahović-Palčevski V., Wendykowska K., Wettermark B., Zara C., Gustafsson L.L., Expert Review of Pharmacoeconomics & Outcomes Research, vol 10, n°6, 2010/12, 707-722.
On Expert reviews site  1807
Social Capital, Human Capital and Health: What is the Evidence?
Scheffler R. M., Petris N. C., Borgonovi F., Brown T. T., Sassi F., Dourgnon P., Sirven N. Paris : OCDE : Centre pour la recherche et l’innovation dans l’enseignement (CERI) ; Irdes, 2010/07, 45 p.
On Ocde site 
1805
Use of Generics - A Critical Cost Containment Measure for All Healthcare Professionals in Europe ?
Godman B., Shrank W., Wettermark B., Andersen M., Bishop I., Burkhardt T., Garuolienè K., Kalaba M., Laius O., Joppi R., Sermet C., Schwabe U., Teixeira I., Cankat Tulunay F., Wendykowska K., Zara C., L. Gustafsson L., Pharmaceuticals, vol 3, n°2, 2010, 2470-2494.
On MDPI site 
1798 Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Adamski J., Godman B., Ofierska-Sujkowska G., Osinska B., Herholzl H., Wendykowska K., Laius O., Jan S., Sermet C., Zara C., Kalaba M., Gustafsson R., Garuoliene K., Haycox A., Garattini S., Gustafsson L.L., BMC Health Services Research, vol 10, n°153, 1-29, 2010/06.
On Biomedcentral site 
1797
Health expenditure models : A comparison using panel data.
Albouy V., Davezies L., Debrand T., Economic Modelling, vol 27, n°4 2010/07, 791-803.
On Science Direct site 
1792
Are health problems systemic? Politics of access and choice under Beveridge and Bismarck systems.
Or Z., Cases C., Lisac M., Vrangbæk K., Winblad U. and Bevan G., Health Economics, Policy and Law, 1-25.
On Cambrige University Press site 
1785
Health Expenditure Models: a Comparison of Five Specifications Using Panel Data.
Albouy V., Davezies L., Debrand T., Série des documents de travail (Insee) n° G2010/02, 2010/02, 31 p.
On the Insee site 
1778
Ongoing pharmaceutical reforms in France : Implications for Key Stakeholder Groups.
Sermet C., Andrieu V., Godman B., Van Ganse E., Haycox A . , Reynier J.P., Applied Health Economics and Health Policy, vol 8, n°1, 2010, 7-24
Abstract 
1770
The preferred doctor scheme : A political reading of a French experiment of Gate-keeping.
Dourgnon P., Naiditch M., Health Policy, in press, 2009/10, 1-6
Abstract 
1754
An empirical investigation of heterogeneity in time preferences and smoking behaviors. Grignon M., Journal of Socio-Economics, Volume 38, Issue 5, 2009/10, Pages 739-751
Abstract 
1747
Pourquoi les systèmes de santé sont-ils organisés différemment ? Grignon M., Revue Economique, n°2, vol 60, 2009/03, 545-558
English abstract 
1731
Impact of medical practices on the cost of cancer treatment.
The case of colon cancer in the Île-de-France region. Renaud T., Com-Ruelle L., Lucas-Gabrielli V., Pratiques et Organisation des soins, vol. 39, n°4, 2008/10-12, 283-295.
Abstract 
1722
Social participation and healthy ageing : An international comparison using SHARE data. Sirven N., Debrand T., Social Science & Medicine, vol 67, n° 12, 2008/12, 2017-2026.
1720
Social capital : A critique and extension, Sirven N., In The Elgar Companion to Social Economics, Davis John B. & Dolsfma Wilfred (Eds.), Cheltenhalm : Edward Elgar Publishing, 2008, 373–389
1705
Cost of illness : An international comparison Australia, Canada, France, Germany and The Netherlands, Heijink R., Noethen M., Renaud T., Koopmanschap M., Polder J., Health Policy, vol 88, n°1 2008/10, 49-61.
Abstract
1695
What can we learn from a cross-country comparison of the costs of child delivery? Bellanger M., Or z., Health Economics, 2008/01-02, vol 17, n° S1, S47-S57
Full text on the Wiley InterScience's site 
1685
The Decommodified Security Ratio: A Tool for Assessing European Social Protection Systems. Menahem G., International Social Security Review , Genève : Aiss, vol. 60, issue 4, p. 69-103, 2007/10-12.
Abstract 
1684
Social Benefits, Economic Security and Growth in Europe. Menahem G., Revue de l’OFCE, n°103 , 2007/12, p. 291-322.
Abstract 
1676
Economic aspects of severe asthma, Laforest L., Com-Ruelle L., Devouassoux G., Pison C., Van Ganse E., La Presse Médicale, vol 37, n°1, 2008/01,117-128.
English abstract 
1669bis
Does free supplementary health insurance help the poor to access health care? Evidence from France.
Grignon M., Perronnin M., Lavis J.N., Chepa working Paper series n° 06-02, Hamilton, ON. McMaster University, 2006, 37 p.
Full text on the McMaster University site
1669
Does free complementary health insurance help the poor to access health care? Evidence from France.
Grignon M., Perronnin M., Lavis J.N., Health Economics,vol 17, n°2, 2008/02, 203-219
Full text on the Wiley Interscience site
1668
The shape of the relationship between mortality and income in France. Jusot F., Annales d’économie et de statistique, Health-Insurance-Equity, 2006/07-12, n° 83-84, 89-122.
1665bis
Unemployment and mortality in France, 1982-2002, Buchmueller T., Grignon M., Jusot F., Chepa working paper series n°07-04, Hamilton, ON: McMaster University, Centre for Health Economics and Policy Analysis (CHEPA), 2007/05, 32p.
Full text on BDSP site 
1661
A microsimulation model of private sector pensions in France. Debrand T., Pennec S. et Privat A.-G., In : Modelling our Future : Population Ageing, Social Security and Taxation, Harding A., Gupta A. Amsterdam : Elsevier, 2007/03, 55-80.
1626
Can physician gate-keeping and patient choice be reconciled in France ? Analysis of recent reform.
Com-Ruelle L., Dourgnon P., Paris V., Eurohealth, 2006, vol.12, n°1, 17-19.
Full text on the LSE site 
1623
The « Health Benefit Basket» in France.
Bellanger M., Cherilova V., Paris V., The European Journal of Health Economics, 2005/12, n° 6, suppl. 1, 24-29.
Full text on Springer site 
1616
Pharmaceutical regulation in France 1980-2003.Paris V., The International Journal of Health Planning and Management, 2005/11, 307-328.
Abstract 
1570
The Impact of Price on Young People's Smoking Behaviour.
Grignon M., Pierrard B., In Journal d'Economie Médicale, vol.22, n° 3, 2004/05, pp. 119-130.
1569
Is the French Health Insurance an Efficient Instrument for Intragenerational Income Redistribution?Jusot F., In Journal d'Economie Médicale, vol.22, n° 3, 2004/05, pp. 99-118.
1555
Obesity morbidity and health care costs in France: an analysis of the 1991-1992 Medical Care Household Survey.
Basdevant A., Charles MA., Detournay B., Eschwege E., Fagnani F., Phillipo M., Pribil C., Sermet C., In International Journal of Obesity vol. 24, n° 2, 2000/02, pp. 151-155.
Full text on the Internatinal Journal of Obesity site 
More on the French Site...
|
Our newsletter 
Subscribe
Contact 
Legal information 
To order 
Sitemap 
Useful links 
Access 
News 
Latest publications 
iPhone Page 
RSS 
January 10th 2011 |